(Q42732005)

6 November 2017

title

Melatonin alleviates lipopolysaccharide-induced hepatic SREBP-1c activation and lipid accumulation in mice (English)

1 reference

6 November 2017

0 references

0 references

Xi Chen

1

1 reference

6 November 2017

Cheng Zhang

2

1 reference

6 November 2017

Mei Zhao

3

1 reference

6 November 2017

Chang-E Shi

4

1 reference

6 November 2017

Ren-Min Zhu

5

1 reference

6 November 2017

Hua Wang

6

1 reference

6 November 2017

Hui Zhao

7

1 reference

6 November 2017

Wei Wei

8

1 reference

6 November 2017

Jia-Bin Li

9

1 reference

6 November 2017

De-Xiang Xu

10

1 reference

6 November 2017

publication date

21 June 2011

1 reference

Journal of Pineal Research

6 November 2017

published in

1 reference

6 November 2017

volume

51

1 reference

6 November 2017

issue

4

1 reference

6 November 2017

page(s)

416-425

1 reference

Epidemiology of non-alcoholic fatty liver disease in China.

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Reactive oxygen species contribute to lipopolysaccharide-induced teratogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Elevated endotoxin levels in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Melatonin stimulates brain glutathione peroxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Melatonin prevents endotoxin-induced circulatory failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Fatty acid transport: the roads taken

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Functional and structural basis of carnitine palmitoyltransferase 1A deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Melatonin attenuates lipopolysaccharide-induced down-regulation of pregnane X receptor and its target gene CYP3A in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

The acute phase response is associated with retinoid X receptor repression in rodent liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2011.00905.X

10.1111/J.1600-079X.2011.00905.X

21 January 2018

Identifiers

DOI

1 reference

6 November 2017

1 reference